Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a).
Ontology highlight
ABSTRACT: Lipoprotein (a) [Lp(a)] is a risk factor for CVD and a target of therapy, but Lp(a) measurements are not globally standardized. Commercially available assays generally use polyclonal antibodies that detect multiple sites within the kringle (K)IV2 repeat region of Lp(a) and may lead to inaccurate assessments of plasma levels. With increasing awareness of Lp(a) as a cardiovascular risk factor and the active clinical development of new potential therapeutic approaches, the broad availability of reagents capable of providing isoform independence of Lp(a) measurements is paramount. To address this issue, we generated a murine monoclonal antibody that binds to only one site on apo(a). A BALB/C mouse was immunized with a truncated version of apo(a) that contained eight total KIV repeat
SUBMITTER: Gonen A
PROVIDER: S-EPMC7469883 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA